F17.200
Nicotine dependence, unspecified, uncomplicated
Clinical Classification Guidelines
Inclusion Terms
- Tobacco use disorder, mild
- Tobacco use disorder, moderate
- Tobacco use disorder, severe
Medical Intelligence & Overview
Nicotine dependence, often associated with tobacco use disorder, is a condition where an individual develops a strong craving and habitual use of nicotine-containing products, such as cigarettes, cigars, or smokeless tobacco. The ICD-10 code F17.200 specifically refers to nicotine dependence that is unspecified and uncomplicated, indicating that it is present without any significant associated health complications. Recognizing this condition is essential for those aiming to understand the impact of tobacco on overall health and seeking support for cessation.
Causes & Symptoms
Clinical Causes: Genetic predisposition affecting the brain's response to nicotine Repeated exposure to nicotine from tobacco products Environmental influences, such as peer pressure or cultural norms favoring tobacco use Psychological factors including stress, anxiety, or depression that lead individuals to use tobacco as a coping mechanism Advertising and marketing targeting vulnerable populations Situational triggers that reinforce tobacco use habits, such as social gatherings or break times at work
Key Symptoms: Strong cravings or urges to use tobacco Difficulty reducing or abstaining from tobacco despite knowing health risks Persistent desire or unsuccessful attempts to quit Tolerance, requiring increased amounts of tobacco to achieve the same effect Withdrawal symptoms when attempting to stop, such as irritability, anxiety, or difficulty concentrating Neglect of responsibilities or social activities due to tobacco use Using tobacco in hazardous situations, like while driving or operating machinery
Diagnostic & Treatment
Diagnosis Path: Diagnosis of nicotine dependence is primarily based on clinical evaluation, including detailed patient history regarding tobacco use patterns, cravings, and attempts to quit. Healthcare providers may utilize standardized questionnaires or criteria to assess the severity of tobacco use disorder. There are no specific laboratory tests for nicotine dependence, but blood or saliva tests can determine recent nicotine exposure. The diagnosis of 'unspecified' indicates that specific details about the level of severity, such as mild, moderate, or severe, are not provided or documented.
Treatment Protocols: Managing nicotine dependence typically involves a combination of behavioral interventions and pharmacotherapy. The goal is to help individuals quit smoking and manage withdrawal symptoms effectively. Common approaches include: - Behavioral counseling, such as cognitive-behavioral therapy or support groups, to address psychological aspects and develop coping strategies. - Pharmacological aids like nicotine replacement therapy (patches, gums, lozenges), bupropion, or varenicline to reduce withdrawal symptoms and cravings. - Setting a quit date and developing a personalized quit plan. - Providing continuous support and follow-up to prevent relapse. While this overview provides general strategies, individuals should consult healthcare providers for tailored treatment plans based on their specific needs and health status.
Clinical Advice & FAQs
Billing Guidance
Is F17.200 a billable ICD-10 code?
Yes, F17.200 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F17.200?
Clinical documentation must specify the nature of Nicotine dependence, unspecified, uncomplicated and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
